Meloxicam is an enolcarboxamide with preferential COX-2 inhibitory activity ... with placebo or other nonsteroidal anti-inflammatory drugs (NSAIDs). Overall, the efficacy of meloxicam was ...

Purpose: A summary of the basic science underlying the current controversies regarding cyclooxygenase-2 (COX-2)-selective nonsteroidal antiinflammatory drugs (NSAIDs), including data on their ...

Strides strengthens anti-inflammatory portfolio with US FDA approval for celecoxib capsules 100 mg, 200 mg, & 400 mg: Our Bureau, Bengaluru Wednesday, April 30, 2025, 17:45 Hrs [I ...

Red-hot Journalism is the 3-1 morning-line favorite for the 151st Kentucky Derby with a favorable No. 8 post position that ...

Getting your Trinity Audio player ready... Arrests The following were arrested by the Davie County Sheriff’s Office. April 26: George Scott Cristina, 56, of Frost Road, Advance, felony possession of ...

Police arrested and charged a citizen(s) with shoplifting, possession of drug paraphernalia, and a warrant service at a ...

Announced on The Scott Mills Breakfast Show, Sara Cox and Richie Anderson will both be heading to Switzerland Announced on BBC Radio 2's The Scott Mills Breakfast Show, Sara Cox will be joining ...

Mosaic Therapeutics has secured the latest pieces in its combination medicine strategy by licensing two clinical stage tumor ...

Announced on BBC Radio 2's The Scott Mills Breakfast Show, Sara Cox will be joining Scott, Rylan and Richie Anderson in this year's Radio 2 presenting line-up for Eurovision 2025! Sara and Richie ...

A non-opioid drug for pain developed by UK biotech Levicept, with a new mechanism of action, has shown it can reduce pain associated with osteoarthritis in a phase 2 trial. Neurotrophin-3 (NT-3 ...

Vyloy is the first CLDN18.2-targeting drug to reach the US market but has already been approved in Japan as well as in the EU and GB. Astellas refiled its marketing application in May, and the FDA ...

A recent preclinical study led by researchers at McGill University has identified two promising drug candidates—o-Vanillin and RG-7112—that could tackle chronic low back pain at its source by ...